US 7803812
Biphenyl compounds useful as muscarinic receptor antagonists
granted A61KA61K31/4545A61K45/06
Quick answer
US patent 7803812 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4545, A61K45/06, A61K9/124, A61K9/1623